Based on these in vitro findings, we used subcutaneous xenograft mouse models and found that TTPAL knockdown in ESCC cells markedly inhibited the increase of tumor volume over the entire assay period, leading to a decrease in the final tumor weight (Fig. 2E and F and Supplementary Fig. 1H). The gene discussed is TTPAL; the disease is esophageal squamous cell carcinoma.